2 days ago
ASX 200 climbs on Friday as hearing implant company Cochlear slides amid lacklustre 2025 financial year result
The ASX 200 lifted on Friday as the results of Australia's largest companies continue to roll in this reporting season.
The index grew 0.3 per cent in the first hour of trading.
Hearing implant maker Cochlear fell 2.2 per cent after it posted a nine per cent profit jump to $389m for the 2025 financial year.
It also revealed a five per cent increase in its full-year dividend to $4.30.
Despite the company's profit lifting, RBC Capital Markets analyst Craig Wong-Pan said the result was poor as it came in at the low end of the company's profit range.
"We expect the stock to underperform the market today," Mr Wong-Pan said.
Property developer Mirvac sank 1.5 per cent after revealing its revenue fell 10 per cent while packaging company Amcor crashed 10.4 per cent amid disappointment over its full year result.
Meanwhile, petrol company Ampol jumped 6.9 per cent after it announced a $1.1b acquisition of convenience store company EG Australia.
In the US, Bloomberg reported the Trump Administration is considering taking a stake in semiconductor manufacturer and designed Intel, boosting the company's share price about seven per cent.
On Thursday, the Dow Jones, Nasdaq and the S&P 500 all finished flat.
London's FTSE 250 sank 0.2 per cent while Germany's DAX rose 0.8 per cent and the STOXX Europe 600 added 0.6 per cent on Thursday.
New Zealand's NZX 50 grew 0.4 per cent while Japan's Nikkei 225 added 0.7 per cent since trading opened on Friday.
